<< Back

Upcoming Schedule of InSight program

Showing top 6 upcoming show times. Show times are sorted in increasing order of start time.

  1. Fri 11:00 PM, 22 Nov 2024 on CNA channel
    Failed inspections and drug recalls have tarnished the reputation of India's drugmakers. By end 2024, manufacturers must comply with new standards. What explains poor quality control in Indian pharma?
  2. Sat 1:02 PM, 23 Nov 2024 on CNA channel
    Insight investigates and analyses topical issues that impact Asia and the rest of the world.
  3. Mon 1:00 AM, 25 Nov 2024 on CNA channel
    Insight investigates and analyses topical issues that impact Asia and the rest of the world.
  4. Mon 5:02 PM, 25 Nov 2024 on CNA channel
    Insight investigates and analyses topical issues that impact Asia and the rest of the world.
  5. Tue 3:00 AM, 26 Nov 2024 on CNA channel
    Failed inspections and drug recalls have tarnished the reputation of India's drugmakers. By end 2024, manufacturers must comply with new standards. What explains poor quality control in Indian pharma?
  6. Wed 4:00 PM, 27 Nov 2024 on CNA channel
    Failed inspections and drug recalls have tarnished the reputation of India's drugmakers. By end 2024, manufacturers must comply with new standards. What explains poor quality control in Indian pharma?

Past Schedule of InSight program

Showing top 3 upcoming show times. Show times are sorted in increasing order of start time.

  1. Fri 10:00 AM, 22 Nov 2024 on CNA channel
    Failed inspections and drug recalls have tarnished the reputation of India's drugmakers. By end 2024, manufacturers must comply with new standards. What explains poor quality control in Indian pharma?
  2. Fri 5:00 AM, 22 Nov 2024 on CNA channel
    Failed inspections and drug recalls have tarnished the reputation of India's drugmakers. By end 2024, manufacturers must comply with new standards. What explains poor quality control in Indian pharma?
  3. Thu 9:00 PM, 21 Nov 2024 on CNA channel
    Failed inspections and drug recalls have tarnished the reputation of India's drugmakers. By end 2024, manufacturers must comply with new standards. What explains poor quality control in Indian pharma?